|
Class 3 Device Recall Staarvisc |
 |
Date Initiated by Firm |
October 08, 2003 |
Date Posted |
November 13, 2003 |
Recall Status1 |
Terminated 3 on August 09, 2004 |
Recall Number |
Z-0109-04 |
Recall Event ID |
27457 |
PMA Number |
P000046 |
Product Classification |
Aid, Surgical, Viscoelastic - Product Code LZP
|
Product |
Staarvisc II Sodium Hyaluronate 0.8 mL 12mg/mL Syringe. Sterile. Rx. For intraocular use.
P/N490-001 Distributed by: STAAR Surgical Inc., Monrovia CA |
Code Information |
Lot Number: B020122E |
Recalling Firm/ Manufacturer |
Anika Therapeutics 240 West Cummings Park Woburn MA 01801
|
For Additional Information Contact |
Julie Broderick 781-932-6616 Ext. 107
|
Manufacturer Reason for Recall |
Stability failure at the 20 month for viscosity specification
|
FDA Determined Cause 2 |
Other |
Action |
Anika Therapeutics issued notification on 10/8/2003 by fax and FedEx to three Distributors. Distributors were requested to subrecall to their customers. |
Quantity in Commerce |
1526 units |
Distribution |
CA, MO, NC,VA |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
PMA Database |
PMAs with Product Code = LZP and Original Applicant = Anika Therapeutics, Inc.
|
|
|
|